Trandolapril intermediate preparation method

A technology for trandolapril and intermediates, which is applied in the new field of preparation of key intermediates, can solve the problems of unfavorable environmental protection, large-scale production, reduced synthesis cost, and small synthesis scale, and achieve solvent recyclability, convenient operation, Simple operation effect

Active Publication Date: 2014-09-17
SHANGHAI JIAO TONG UNIV
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Yet, this technique also has some places to be improved: 1) raw material N-p-toluenesulfonyl-7-azabicyclo[4.1.0]heptane is more expensive in this route, if start with cyclohexene Synthesize the compound from raw materials in advance, and the synthesis cost will be further reduced
2) In the synthetic route, the protective group on N is removed using sodium naphthalene as a reagent and separated by a resin column. The synthetic scale is small and the operation is troublesome
[0006] In summary, the existing preparation methods of (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid and its benzyl ester have the disadvantages of long process route, complex operation, etc., and use a large amount of toxic Harmful and expensive reagents, high cost, low overall yield, not conducive to environmental protection and large-scale production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Trandolapril intermediate preparation method
  • Trandolapril intermediate preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] (1) Synthesis of cyclohexaneziridine (hereinafter referred to as compound 2)

[0055] Chloramine-T (500g, 1.775mol), cyclohexene (164.0g, 2.0mol), iodine (28.2g, 0.11mol) and benzyltrimethylammonium bromide (20.4g, 0.088mol) were added to 1000mL tetrahydrofuran and In a mixed solvent of 500 mL of water, react at room temperature for 24 h, distill off tetrahydrofuran, extract the aqueous phase with ethyl acetate (500 mL×3), combine the organic phases, dry with anhydrous sodium sulfate, filter with suction, remove the solvent by rotary evaporation, and use Recrystallized from ethanol to obtain white crystals (326.7g, 65%).

[0056] (2) Synthesis of mixed trans-N-p-methylbenzenesulfonyl-2-(2-propenyl)-cyclohexylamine (hereinafter referred to as compound 3)

[0057] Dissolve cyclohexaneziridine (25.1g, 0.1mol) and copper bromide (2.23g, 0.01mol) in 200mL ether, and allylmagnesium bromide (29.0g, 0.2mol) at -40°C , slowly dropwise, stirring overnight. The reaction was que...

Embodiment 2

[0075] (1) Synthesis of cyclohexaneziridine (hereinafter referred to as compound 2)

[0076] Chloramine T (500.0g, 1.775mol), cyclohexene (164g, 2.0mol), iodine (28.2g, 0.11mol) and benzyltrimethylammonium chloride (16.5g, 0.088mol) were added to 1000mL tetrahydrofuran and 500mL In a mixed solvent of water, react at room temperature for 24h. The tetrahydrofuran was evaporated, the aqueous phase was extracted with ethyl acetate (500mL×3), the organic phases were combined, dried with anhydrous sodium sulfate, filtered with suction, the solvent was removed by rotary evaporation, and the product was recrystallized with ethanol to obtain white crystals (270.1g ,60%).

[0077] (2) Synthesis of mixed trans-N-p-methylbenzenesulfonyl-2-(2-propenyl)-cyclohexylamine (hereinafter referred to as compound 3)

[0078] Dissolve cyclohexaneziridine (25.1g, 0.1mol) and copper bromide (2.23g, 0.01mol) in 200mL ether, and allylmagnesium bromide (58g, 0.4mol) at -50°C, Add dropwise slowly and s...

Embodiment 3

[0094] (1) Synthesis of cyclohexaneziridine (hereinafter referred to as compound 2)

[0095] Add 1000 mL of acetonitrile and In a mixed solvent of 500mL water, react at room temperature for 24h. Acetonitrile was evaporated, the aqueous phase was extracted with ethyl acetate (500mL×3), the organic phases were combined, dried with anhydrous sodium sulfate, filtered with suction, and the solvent was removed by rotary evaporation, and the product was recrystallized with ethanol to obtain white crystals (275g, 61%).

[0096] (2) Synthesis of mixed trans-N-p-methylbenzenesulfonyl-2-(2-propenyl)-cyclohexylamine (hereinafter referred to as compound 3)

[0097] Cyclohexane aziridine (25.1g, 0.1mol) and copper bromide (2.23g, 0.01mol) were dissolved in 200mL tetrahydrofuran, and allylmagnesium bromide (58.0g, 0.4mol) was , slowly dropwise, stirring overnight. The reaction was quenched with water, extracted with ethyl acetate (250 mL×3), the organic phases were combined, dried over a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a trandolapril intermediate preparation method which is as follows: reacting cyclohexene and chloramines-T as starting materials to obtain cyclohexane aziridine; reacting the cyclohexane aziridine with an allyl Grignard reagent to obtain trans-N-p-toluenesulfonyl-2-(2-propenyl)-cyclohexylamine, obtaining trans D,L-N-p-toluenesulfonyl-octahydro-1H-indole-2-formic acid under the effect of an oxidizing agent, performing methyl esterification protection on free carboxyl to obtain trans D,L-N-p-toluenesulfonyl-octahydro-1H-indole-2-methyl formate, after removal of Ts protecting group connecting with nitrogen and hydrolysis, performing benzyl esterification reaction to obtain trans D,L-octahydro-1H-indole-2-benzyl formate, and then separating and resolving to obtain a trandolapril key intermediate (2S, 3aR, 7aS)-octahydro-1H-indole-2-benzyl formate. The trandolapril intermediate preparation method has the advantages of cheap and easily obtained materials, environmentally friendly preparation process and simple operation and post-treatment.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a novel preparation method of a key intermediate of trandolapril in cardiovascular drugs. Background technique [0002] Trandolapril, chemical name: (2S,3aR,7aS)-[(2S)-{[(1S)-(ethoxycarbonyl)-phenylpropyl]amino}]-propionyl]- Octahydro-1H-indole-2-carboxylic acid, developed by France Roussel Uclaf Company. It is a long-acting angiotensin-converting enzyme inhibitor, which can treat a variety of cardiovascular diseases, and has the advantages of significant curative effect, long acting time, and small side effects. Further research found that trandolapril can effectively improve peripheral neuropathy in normotensive diabetic patients. [0003] The main part of the trandolapril structure is the same as many angiotensin-converting enzyme inhibitors (such as enalapril), and the difference lies in their side chains. Therefore, when preparing trandolapril, the side chains (2S, 3aR ,7aS)-oc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/42
CPCY02P20/55C07D209/42
Inventor 张万斌刘德龙申杰峰时涛
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap